15.35澳幣0.06(0.39%)
2024/04/25更新
績效 / 1月4.04%
3月1.28%
1年3.44%
晨星評等-
- 1.現金0.00%
- 2.股票28.80%
- 3.債券0.00%
- 4.其他71.20%
- 1.美國71.20%
- 2.歐洲不包含歐元區17.99%
- 3.英國4.62%
- 4.日本2.24%
- 5.歐元區2.19%
- 1.健康護理98.90%
- 2.基本物料0.47%
- 3.工業0.32%
- 4.防守性消費0.31%
- 1.Eli Lilly and Co8.21%
- 2.Novo Nordisk A/S Class B7.97%
- 3.UnitedHealth Group Inc7.46%
- 4.Merck & Co Inc6.04%
- 5.Roche Holding AG4.92%
- 6.GSK PLC4.69%
- 7.Regeneron Pharmaceuticals Inc4.62%
- 8.Elevance Health Inc4.28%
- 9.Vertex Pharmaceuticals Inc4.27%
- 10.Amgen Inc4.18%
- 1.現金0.00%
- 2.股票28.80%
- 3.債券0.00%
- 4.其他71.20%
- 1.健康護理98.90%
- 2.基本物料0.47%
- 3.工業0.32%
- 4.防守性消費0.31%
- 1.美國71.20%
- 2.歐洲不包含歐元區17.99%
- 3.英國4.62%
- 4.日本2.24%
- 5.歐元區2.19%
- 1.Eli Lilly and Co8.21%
- 2.Novo Nordisk A/S Class B7.97%
- 3.UnitedHealth Group Inc7.46%
- 4.Merck & Co Inc6.04%
- 5.Roche Holding AG4.92%
- 6.GSK PLC4.69%
- 7.Regeneron Pharmaceuticals Inc4.62%
- 8.Elevance Health Inc4.28%
- 9.Vertex Pharmaceuticals Inc4.27%
- 10.Amgen Inc4.18%